Combination therapy for macular edema secondary to retinal vein occlusion.
Publication
, Journal Article
Schneider, EW; Mruthyunjaya, P; Hariprasad, SM
Published in: Ophthalmic Surg Lasers Imaging Retina
2013
Duke Scholars
Published In
Ophthalmic Surg Lasers Imaging Retina
DOI
EISSN
2325-8179
Publication Date
2013
Volume
44
Issue
5
Start / End Page
434 / 438
Location
United States
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Retinal Vein Occlusion
- Macular Edema
- Laser Therapy
- Humans
- Drug Therapy, Combination
- Combined Modality Therapy
- Angiogenesis Inhibitors
- Adrenal Cortex Hormones
Citation
APA
Chicago
ICMJE
MLA
NLM
Schneider, E. W., Mruthyunjaya, P., & Hariprasad, S. M. (2013). Combination therapy for macular edema secondary to retinal vein occlusion. Ophthalmic Surg Lasers Imaging Retina, 44(5), 434–438. https://doi.org/10.3928/23258160-20130909-02
Schneider, Eric W., Prithvi Mruthyunjaya, and Seenu M. Hariprasad. “Combination therapy for macular edema secondary to retinal vein occlusion.” Ophthalmic Surg Lasers Imaging Retina 44, no. 5 (2013): 434–38. https://doi.org/10.3928/23258160-20130909-02.
Schneider EW, Mruthyunjaya P, Hariprasad SM. Combination therapy for macular edema secondary to retinal vein occlusion. Ophthalmic Surg Lasers Imaging Retina. 2013;44(5):434–8.
Schneider, Eric W., et al. “Combination therapy for macular edema secondary to retinal vein occlusion.” Ophthalmic Surg Lasers Imaging Retina, vol. 44, no. 5, 2013, pp. 434–38. Pubmed, doi:10.3928/23258160-20130909-02.
Schneider EW, Mruthyunjaya P, Hariprasad SM. Combination therapy for macular edema secondary to retinal vein occlusion. Ophthalmic Surg Lasers Imaging Retina. 2013;44(5):434–438.
Published In
Ophthalmic Surg Lasers Imaging Retina
DOI
EISSN
2325-8179
Publication Date
2013
Volume
44
Issue
5
Start / End Page
434 / 438
Location
United States
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Retinal Vein Occlusion
- Macular Edema
- Laser Therapy
- Humans
- Drug Therapy, Combination
- Combined Modality Therapy
- Angiogenesis Inhibitors
- Adrenal Cortex Hormones